IN THE NEWS

THE LATEST NEWS

SomaLogic Licenses GNS Healthcare’s REFS™ technology for analysis of its SOMAscan®- derived proteomic data

Rare Disease Report Covers Alexion-GNS REFS Licensing Agreement

GNS Healthcare Licenses REFS™ Causal Machine Learning and Simulation Platform to Alexion to Accelerate Discovery of New Treatments for Rare Diseases